Annual Operating Profit
$25.44 M
+$62.20 M+169.20%
30 June 2024
Summary:
MEI Pharma annual operaing income is currently $25.44 million, with the most recent change of +$62.20 million (+169.20%) on 30 June 2024. During the last 3 years, it has risen by +$85.86 million (+142.10%). MEIP annual operating profit is now at all-time high.MEIP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$8.35 M
-$271.00 K-3.35%
30 September 2024
Summary:
MEI Pharma quarterly operating income is currently -$8.35 million, with the most recent change of -$271.00 thousand (-3.35%) on 30 September 2024. Over the past year, it has dropped by -$63.63 million (-115.11%). MEIP quarterly operating profit is now -115.11% below its all-time high of $55.28 million, reached on 30 September 2023.MEIP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$38.19 M
-$63.63 M-250.12%
30 September 2024
Summary:
MEI Pharma TTM operating income is currently -$38.19 million, with the most recent change of -$63.63 million (-250.12%) on 30 September 2024. Over the past year, it has dropped by -$74.93 million (-203.96%). MEIP TTM operating profit is now -203.96% below its all-time high of $36.74 million, reached on 30 September 2023.MEIP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +169.2% | -115.1% | -204.0% |
| 3 y3 years | +142.1% | +58.5% | +43.6% |
| 5 y5 years | +155.0% | +33.8% | +21.8% |
MEIP Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.7% | -115.1% | +61.3% | -204.0% | +49.4% |
| 5 y | 5 years | at high | +133.7% | -115.1% | +61.3% | -204.0% | +49.4% |
| alltime | all time | at high | +133.7% | -115.1% | +61.3% | -204.0% | +49.4% |
MEI Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.35 M(+3.4%) | -$38.19 M(-250.1%) |
| June 2024 | $25.44 M(-169.2%) | -$8.08 M(-17.8%) | $25.44 M(+13.4%) |
| Mar 2024 | - | -$9.83 M(-17.6%) | $22.44 M(+41.3%) |
| Dec 2023 | - | -$11.93 M(-121.6%) | $15.88 M(-56.8%) |
| Sept 2023 | - | $55.28 M(-598.9%) | $36.74 M(-199.9%) |
| June 2023 | -$36.76 M(-51.3%) | -$11.08 M(-32.4%) | -$36.76 M(-12.2%) |
| Mar 2023 | - | -$16.39 M(-283.6%) | -$41.88 M(-11.0%) |
| Dec 2022 | - | $8.93 M(-149.0%) | -$47.05 M(-36.1%) |
| Sept 2022 | - | -$18.22 M(+12.5%) | -$73.60 M(-2.5%) |
| June 2022 | -$75.48 M(+24.9%) | -$16.20 M(-24.9%) | -$75.48 M(+1.0%) |
| Mar 2022 | - | -$21.56 M(+22.3%) | -$74.76 M(+7.4%) |
| Dec 2021 | - | -$17.63 M(-12.3%) | -$69.60 M(+2.7%) |
| Sept 2021 | - | -$20.11 M(+29.9%) | -$67.75 M(+12.1%) |
| June 2021 | -$60.42 M(+135.1%) | -$15.47 M(-5.6%) | -$60.42 M(+80.5%) |
| Mar 2021 | - | -$16.39 M(+3.9%) | -$33.47 M(+13.4%) |
| Dec 2020 | - | -$15.77 M(+23.4%) | -$29.52 M(+14.2%) |
| Sept 2020 | - | -$12.78 M(-211.4%) | -$25.86 M(+0.6%) |
| June 2020 | -$25.70 M(-44.4%) | $11.48 M(-192.2%) | -$25.70 M(-47.5%) |
| Mar 2020 | - | -$12.44 M(+2.8%) | -$48.92 M(-0.4%) |
| Dec 2019 | - | -$12.11 M(-4.1%) | -$49.10 M(+0.5%) |
| Sept 2019 | - | -$12.62 M(+7.4%) | -$48.84 M(+5.6%) |
| June 2019 | -$46.24 M(+61.8%) | -$11.75 M(-6.9%) | -$46.24 M(+10.2%) |
| Mar 2019 | - | -$12.62 M(+6.5%) | -$41.97 M(+18.5%) |
| Dec 2018 | - | -$11.85 M(+18.1%) | -$35.41 M(+19.1%) |
| Sept 2018 | - | -$10.03 M(+34.3%) | -$29.73 M(+4.0%) |
| June 2018 | -$28.59 M(-1299.1%) | -$7.47 M(+23.4%) | -$28.59 M(+11.9%) |
| Mar 2018 | - | -$6.05 M(-1.9%) | -$25.55 M(+26.7%) |
| Dec 2017 | - | -$6.17 M(-30.6%) | -$20.17 M(+825.5%) |
| Sept 2017 | - | -$8.89 M(+100.2%) | -$2.18 M(-191.4%) |
| June 2017 | $2.38 M(-111.4%) | -$4.44 M(+562.4%) | $2.38 M(+138.2%) |
| Mar 2017 | - | -$670.00 K(-105.7%) | $1.00 M(-126.8%) |
| Dec 2016 | - | $11.82 M(-373.3%) | -$3.74 M(-81.9%) |
| Sept 2016 | - | -$4.32 M(-25.7%) | -$20.68 M(-1.5%) |
| June 2016 | -$21.00 M(-35.9%) | -$5.82 M(+7.6%) | -$21.00 M(+0.6%) |
| Mar 2016 | - | -$5.41 M(+5.5%) | -$20.87 M(-14.5%) |
| Dec 2015 | - | -$5.13 M(+10.4%) | -$24.42 M(-14.0%) |
| Sept 2015 | - | -$4.65 M(-18.3%) | -$28.41 M(-13.3%) |
| June 2015 | -$32.77 M(+20.4%) | -$5.69 M(-36.5%) | -$32.77 M(-8.1%) |
| Mar 2015 | - | -$8.96 M(-1.7%) | -$35.64 M(+4.6%) |
| Dec 2014 | - | -$9.12 M(+1.3%) | -$34.09 M(+8.8%) |
| Sept 2014 | - | -$9.01 M(+5.2%) | -$31.32 M(+15.0%) |
| June 2014 | -$27.23 M | -$8.56 M(+15.6%) | -$27.23 M(+24.3%) |
| Mar 2014 | - | -$7.41 M(+16.6%) | -$21.90 M(+26.9%) |
| Dec 2013 | - | -$6.35 M(+29.2%) | -$17.26 M(+26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | -$4.91 M(+52.0%) | -$13.67 M(+21.8%) |
| June 2013 | -$11.22 M(+33.7%) | -$3.23 M(+16.8%) | -$11.22 M(+10.1%) |
| Mar 2013 | - | -$2.77 M(+0.4%) | -$10.19 M(+4.8%) |
| Dec 2012 | - | -$2.76 M(+11.8%) | -$9.73 M(+9.0%) |
| Sept 2012 | - | -$2.47 M(+11.9%) | -$8.93 M(+6.3%) |
| June 2012 | -$8.39 M(+30.1%) | -$2.20 M(-4.3%) | -$8.39 M(+13.8%) |
| Mar 2012 | - | -$2.30 M(+17.6%) | -$7.38 M(+15.1%) |
| Dec 2011 | - | -$1.96 M(+1.2%) | -$6.41 M(-2.2%) |
| Sept 2011 | - | -$1.93 M(+62.8%) | -$6.55 M(+1.6%) |
| June 2011 | -$6.45 M(-19.2%) | -$1.19 M(-10.8%) | -$6.45 M(-9.4%) |
| Mar 2011 | - | -$1.33 M(-36.7%) | -$7.12 M(-11.2%) |
| Dec 2010 | - | -$2.10 M(+14.9%) | -$8.02 M(+8.8%) |
| Sept 2010 | - | -$1.83 M(-1.5%) | -$7.38 M(-7.3%) |
| June 2010 | -$7.98 M(-28.6%) | -$1.86 M(-16.8%) | -$7.95 M(-31.0%) |
| Mar 2010 | - | -$2.23 M(+53.3%) | -$11.52 M(+2.9%) |
| Dec 2009 | - | -$1.46 M(-39.5%) | -$11.19 M(-1.3%) |
| Sept 2009 | - | -$2.41 M(-55.6%) | -$11.34 M(+1.4%) |
| June 2009 | -$11.18 M(-14.5%) | -$5.42 M(+184.9%) | -$11.18 M(+13.7%) |
| Mar 2009 | - | -$1.90 M(+19.1%) | -$9.83 M(-12.7%) |
| Dec 2008 | - | -$1.60 M(-29.0%) | -$11.26 M(-5.9%) |
| Sept 2008 | - | -$2.25 M(-44.8%) | -$11.97 M(-8.5%) |
| June 2008 | -$13.08 M(-5.3%) | -$4.08 M(+22.3%) | -$13.08 M(+18.4%) |
| Mar 2008 | - | -$3.33 M(+44.2%) | -$11.05 M(+17.0%) |
| Dec 2007 | - | -$2.31 M(-31.4%) | -$9.44 M(+1.5%) |
| Sept 2007 | - | -$3.37 M(+64.8%) | -$9.30 M(-32.7%) |
| June 2007 | -$13.82 M(+87.1%) | -$2.04 M(+18.6%) | -$13.82 M(+12.1%) |
| Mar 2007 | - | -$1.72 M(-20.8%) | -$12.33 M(-11.0%) |
| Dec 2006 | - | -$2.17 M(-72.4%) | -$13.86 M(+2.9%) |
| Sept 2006 | - | -$7.88 M(+1327.5%) | -$13.46 M(+82.3%) |
| June 2006 | -$7.38 M(+15.0%) | -$552.00 K(-83.0%) | -$7.38 M(-17.1%) |
| Mar 2006 | - | -$3.25 M(+82.9%) | -$8.91 M(+20.4%) |
| Dec 2005 | - | -$1.78 M(-1.4%) | -$7.40 M(+5.8%) |
| Sept 2005 | - | -$1.80 M(-13.2%) | -$6.99 M(+8.9%) |
| June 2005 | -$6.42 M(-24.8%) | -$2.08 M(+19.3%) | -$6.42 M(+15.8%) |
| Mar 2005 | - | -$1.74 M(+26.5%) | -$5.55 M(+3.7%) |
| Dec 2004 | - | -$1.38 M(+11.8%) | -$5.35 M(-38.2%) |
| Sept 2004 | - | -$1.23 M(+2.4%) | -$8.65 M(+1.4%) |
| June 2004 | -$8.54 M(+181.5%) | -$1.20 M(-22.1%) | -$8.54 M(+0.2%) |
| Mar 2004 | - | -$1.54 M(-67.1%) | -$8.52 M(+12.5%) |
| Dec 2003 | - | -$4.68 M(+320.3%) | -$7.58 M(+161.6%) |
| Sept 2003 | - | -$1.11 M(-6.1%) | -$2.90 M(+62.4%) |
| June 2003 | -$3.03 M(+2386.1%) | -$1.19 M(+98.8%) | -$1.78 M(+198.8%) |
| Mar 2003 | - | -$597.00 K | -$597.00 K |
| June 2002 | -$122.00 K | - | - |
FAQ
- What is MEI Pharma annual operaing income?
- What is the all time high annual operating profit for MEI Pharma?
- What is MEI Pharma annual operating profit year-on-year change?
- What is MEI Pharma quarterly operating income?
- What is the all time high quarterly operating profit for MEI Pharma?
- What is MEI Pharma quarterly operating profit year-on-year change?
- What is MEI Pharma TTM operating income?
- What is the all time high TTM operating profit for MEI Pharma?
- What is MEI Pharma TTM operating profit year-on-year change?
What is MEI Pharma annual operaing income?
The current annual operating profit of MEIP is $25.44 M
What is the all time high annual operating profit for MEI Pharma?
MEI Pharma all-time high annual operaing income is $25.44 M
What is MEI Pharma annual operating profit year-on-year change?
Over the past year, MEIP annual operaing income has changed by +$62.20 M (+169.20%)
What is MEI Pharma quarterly operating income?
The current quarterly operating profit of MEIP is -$8.35 M
What is the all time high quarterly operating profit for MEI Pharma?
MEI Pharma all-time high quarterly operating income is $55.28 M
What is MEI Pharma quarterly operating profit year-on-year change?
Over the past year, MEIP quarterly operating income has changed by -$63.63 M (-115.11%)
What is MEI Pharma TTM operating income?
The current TTM operating profit of MEIP is -$38.19 M
What is the all time high TTM operating profit for MEI Pharma?
MEI Pharma all-time high TTM operating income is $36.74 M
What is MEI Pharma TTM operating profit year-on-year change?
Over the past year, MEIP TTM operating income has changed by -$74.93 M (-203.96%)